#GeneTherapy – perfecting the #ViralVector
Each Gene Therapy has been searching for the perfect viral vector which will deliver a gene to the desired site without a negative interaction..
The Stem Cells USA & Regenerative Medicine Congress is back for its 4th consecutive year. As North America’s leading commercially-focused..
Each Gene Therapy has been searching for the perfect viral vector which will deliver a gene to the desired site without a negative interaction..
AMT, INSERM and Ark Therapeutics shared goal of achieving an approved gene therapy has led them all to explore what are becoming known as the..
AMT’s gene therapy program for the treatment of hemophilia B has today gained orphan drug designation in the US from the FDA. AMT's..
Ark Therapeutics and PsiOxus Therapeutics Ltd have announced that their partnership has successfully achieved its first milestone, by the timely..
Oxford BioMedica announces update on ProSavin® Phase I/II study in Parkinson's Disease, and looked a the safety, efficacy and dose evaluation..
Gene therapy appears to work for haemophilia B patients as scientists show that gene therapy can work for a long period of time in a handful..
The Vatican has long opposed embryonic stem cells research due to the church’s teachings that life begins at conception. However, it..
Advance in aging research - New breakthrough in genetic engineering was able to isolate and purge a category of cells, known as senescent..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
